Novartis gene therapy for leukemia wins US approval – Reuters UK
|
Novartis gene therapy for leukemia wins US approval
Reuters UK Aug 30 (Reuters) – The U.S. Food and Drug Administration (FDA) on Wednesday approved Novartis AG's keenly anticipated leukemia treatment, marking the first gene therapy approval in the United States. The drug, Kymriah, was approved for patients up to … |
